Lord Abbett Health Care Fund Class R6 (LHCVX) is a Health fund with $3.27 Million in assets. The fund allocates 39.30% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 6.77% of total assets. This is followed by Novo Nordisk A/S (6.68%) and Danaher Corp (3.38%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 6.77% | - | - |
| Novo Nordisk A/S | 6.68% | - | - |
| Danaher Corp | 3.38% | - | - |
| Intuitive Surgical Inc | 4.60% | - | - |
| Boston Scientific Corp | 4.40% | - | - |
| Stryker Corp | 3.22% | - | - |
| Thermo Fisher Scientific Inc | 2.70% | - | - |
| Natera Inc | 2.71% | - | - |
| Regeneron Pharmaceuticals Inc | 2.44% | - | - |
| Daiichi Sankyo Co Ltd | 2.40% | - | - |
| Argenx SE | 3.86% | - | - |
| Tarsus Pharmaceuticals Inc | 3.38% | - | - |
| Gilead Sciences Inc | 3.62% | - | - |
| Glaukos Corp | 2.46% | - | - |
| Cencora Inc | 2.72% | - | - |
| AstraZeneca PLC | 3.36% | - | - |
| Guardant Health Inc | 2.71% | - | - |
| UCB SA | 2.69% | - | - |
| EssilorLuxottica SA | 2.67% | - | - |